Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells
- PMID: 14609215
Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells
Abstract
Suppression by T regulatory (T(reg)) cells is essential for the induction of peripheral tolerance. Several types of CD4+ T(reg) cells have been described in a number of systems. Although the precise mechanisms which mediate T(reg) cells effector activity remain to be defined, it is well established that they can suppress Immune responses via cell-cell interactions and/or the production of interleukin (IL)10 and transforming growth factor (TGF)beta. Type 1 T regulatory (T(reg)) cells are defined by their ability to produce high levels of IL10 and TGFbeta, and these cytokines mediate their ability to suppress pathological immune responses in the settings of transplantation, allergy, and autoimmune diseases. T(reg) cell activity is not necessarily beneficial, and they can also suppress immune responses to antigens from tumours and pathogens. The differentiation of T(reg) cells in vivo is likely controlled by certain dendritic cells that promote IL10 production and may express tolerogenic co-stimulatory molecules. Another subset of CD4+ T(reg) cells is defined by constitutive expression of CD25. Naturally occurring human CD4+CD25+ T(reg) cells are distinct from T(reg1) cells. Suppressive CD4+CD25+ T cell clones do not synthesize IL10 but produce TGFbeta which contributes to the suppression of proliferation mediated by these cells. However, CD4+CD25+ T(reg) cells may be involved in the process inducing the differentiation of T(reg1) cells. In conclusions, many questions on the basic biology of T(reg) cells remain to be answered, but the development of therapeutic strategies designed to harness their immunoregulatory effects can already be envisaged.
Similar articles
-
TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.J Leukoc Biol. 2007 Aug;82(2):335-46. doi: 10.1189/jlb.1006644. Epub 2007 May 2. J Leukoc Biol. 2007. PMID: 17475784
-
Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.Int Immunol. 2007 Mar;19(3):227-37. doi: 10.1093/intimm/dxl139. Epub 2007 Feb 7. Int Immunol. 2007. PMID: 17289657
-
CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5. Arch Dermatol Res. 2009. PMID: 18985367 Review.
-
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.J Exp Med. 2003 Dec 15;198(12):1875-86. doi: 10.1084/jem.20030152. J Exp Med. 2003. PMID: 14676299 Free PMC article.
-
CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation.Semin Cancer Biol. 2006 Apr;16(2):150-9. doi: 10.1016/j.semcancer.2005.11.008. Epub 2006 Jan 23. Semin Cancer Biol. 2006. PMID: 16431128 Review.
Cited by
-
Modulation of the mTOR pathway plays a central role in dendritic cell functions after Echinococcus granulosus antigen recognition.Sci Rep. 2021 Aug 26;11(1):17238. doi: 10.1038/s41598-021-96435-z. Sci Rep. 2021. PMID: 34446757 Free PMC article.
-
Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma.Oncoimmunology. 2016 Aug 12;5(8):e1105430. doi: 10.1080/2162402X.2015.1105430. eCollection 2016 Aug. Oncoimmunology. 2016. PMID: 27622054 Free PMC article.
-
Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity.Front Immunol. 2015 Sep 22;6:488. doi: 10.3389/fimmu.2015.00488. eCollection 2015. Front Immunol. 2015. PMID: 26441992 Free PMC article. Review.
-
Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer.Pathol Oncol Res. 2010 Dec;16(4):547-51. doi: 10.1007/s12253-010-9256-8. Epub 2010 Mar 21. Pathol Oncol Res. 2010. PMID: 20306312
-
Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study.Crit Care. 2010;14(1):R3. doi: 10.1186/cc8232. Epub 2010 Jan 11. Crit Care. 2010. PMID: 20064232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials